Built for U.S. Generic Manufacturers

Stop managing market intelligence in spreadsheets

Track approvals, new entrants, pricing pressure, manufacturing exposure, and competitor activity in one place — so your team can make faster portfolio and commercial decisions.

Popular molecules — click to explore

FDA Orange Book & Approvals IQVIA Market Data DailyMed Manufacturing VA Government Pricing NADAC Pricing

Your market signals are public. Your synthesis workflow is the bottleneck.

Generic manufacturers already have access to regulatory filings, pricing feeds, and market data. The problem is turning those scattered sources into timely commercial decisions.

Slow

Weekly review decks lag behind the market. By the time signals reach decision-makers, competitors have already moved.

Fragmented

Approvals in one tab, pricing in a spreadsheet, manufacturing risk in an email chain. No single view ties them together.

Hard to act on

Seeing data is not the problem. Knowing what changed, why it matters, and what to do next — that is the gap.

One workspace for molecule, company, and market intelligence

Search any molecule or manufacturer and see the full commercial picture — regulatory, competitive, pricing, and supply chain — in seconds.

Questions your team can answer in seconds

Who just entered our molecule?
Which strengths have the highest market share?
When does exclusivity expire?
Where are the API and FDF manufacturing sites?
How is our competitor's portfolio performing?
What VA contracts are active and expiring?
What is the current NADAC pricing for this molecule?
Which competitors overlap with our portfolio?
Is there a 483 or supply risk on this site?
Which drugs are in active shortage right now?

Ready to replace your spreadsheets?

Search any molecule above to see the full product intelligence view. Organization intelligence and alerts are available from the top navigation.